Nachrichten zur UroGen Pharma Ltd Aktie

Kirby McInerney LLP Reminds UroGen Pharma Ltd. (URGN) Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who…

Investors can contact the law firm at no cost to learn more about recovering their losses…

…

Urogen Pharma (URGN) saw its shares surge in the last session with trading volume being higher than average. The latest…

Urogen Pharma (URGN) delivered earnings and revenue surprises of -8.11% and 6.08%, respectively, for the quarter ended December 2024. Do…

…

…

…

…

UroGen Pharma stock maintains target post-offering…

…

PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to…

Urogen Pharma (URGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…

…

Urogen Pharma executive sells shares worth over $168k…

…

Urogen Pharma (URGN) delivered earnings and revenue surprises of -7.46% and 5.52%, respectively, for the quarter ended December 2023. Do…